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Background: The capability of OCT to examine the structure of the arterial wall before or
after PCI is superior to those of other imaging modalities. Therefore the application of OCT
during PCI seems logical and has the potential to enhance our performance during the PCI
procedures.
Methods: OCT was performed in fifty-two patients out of which, 45 patients underwent PCI.
Out of these 45 patients, in 25 patients both pre and post PCI OCT assessment was done. In
20 patients only post PCI OCT assessment was done. In seven patients PCI was not done
due to nonsignificant obstruction, these seven patients were not included in final analysis.
Results: Over all OCT leads to management changes in 65% of the time it was used. Alter-
ation of stent length was done in 56% of the cases when evaluated pre PCI. Alteration of
stent diameter was done in 36% cases when evaluated pre PCI. Treatment of malapposition
was done in 24% of total cases. Further balloon dilatation for vessel expansion was done in
15% of total cases. In one case left main stenting was done after proximal edge dissection.
Conclusion: OCT makes better visualization of plaque, thrombus, stent malapposition,
dissection, plaque prolapse and helps in optimization of PCI results. More extensive, long-
term studies will be needed to assess the prognostic implications of these findings.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Atherosclerosis is a diffuse process, with uneven accumula-
tion of plaque over the whole length of the coronary artery.2, þ91 40 23607777, þ91 9
.C. Rath).
2013, Cardiological SocietThe standard coronary angiogram is, in reality, a lumenogram
providing useful information about lumen diameter but
yielding little insight into plaque composition or lesion
morphology.1 More over there is a significant inter-observer
variability in the angiographic classification of lesion848024759 (mobile).
y of India. All rights reserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 3 1e3 732complexity even by skilled operators.2,3 Angiography does not
permit direct visualization of the arterial wall. In contrast,
intravascular imaging (IVUS, OCT etc.) provides cross-
sectional images of both the arterial lumen and wall, allow-
ing correct assessment of true lumen dimensions and archi-
tecture as well as atherosclerotic plaque burden and vessel
wall abnormalities.4 Optical coherence tomography (OCT) is
an optical analog of intravascular ultrasound (IVUS) that can
be used to examine the coronary arteries and has 10-fold
higher resolution than IVUS.5 This technique has been found
to have a high sensitivity and specificity for the classification
of the different types of atherosclerotic plaques6,7 and has also
been utilized to estimate the collagen, macrophage content
and to detect thin fibrous caps in atherosclerotic plaques.8e10
Furthermore, this improved resolution with OCT may help in
interventional procedures and indeedOCThas been applied to
assess the results of stent implantation.11e13 All of these data
have been from outside India and there is no information on
how OCT performs in our clinical milieu. We, therefore, pre-
sent our preliminary experience of using OCT to assess and
guide coronary interventions in India.Fig. 1 e (a) OCT image analysis e Fibrous plaque. (b) OCT
image analysis e Lipid plaque. (c) OCT image analysis e
Calcified plaque.2. Methods
This study was designed as a retrospective, single center
study. After baseline angiogram, consecutive patients who
were posted for OCT guided PCI during Sep 2012 to Mar 2013
were studied. Patients with symptomatic ischemic heart dis-
ease, and a de novo lesion in the native coronary arteries, who
gave consent for OCT were selected for the study. Exclusion
criteria were ostial left main coronary artery disease, PCI to
SVG graft, lesion of large vessel (reference vessel
diameter > 4 mm), totally occluded lesion, lesion of severe
tortuous vessel, serum creatinine > 2 mg/dL, and when use of
antiplatelets and anticoagulants was contraindicated.
Standard protocol was used for performance & interpre-
tation of OCT.14,15 The use of OCT to guide PCI was left at the
operator’s discretion. All procedures were performed by
experienced staff members with established skills. Fifty-two
patients who underwent PCI or diagnostic procedures were
studied by OCT. Pre PCI and post PCI assessments are done in
25 patients. In 20 patients, post PCI assessment was done. 7
patients underwent diagnostic angiogram followed by OCT. In
these 7 patients PCI was not done due to nonsignificant
obstruction and were excluded from final analysis. PCI was
performed according to standard procedure. In patients with
STEMI OCT was used after thrombus suction to see extent of
thrombus and residual stenosis. OCT study was performed
using Lightlab C7XR Frequency Domain OCT system. FD OCT
is much superior to older TD OCT. It electronically scans the
laser wavelength and gives faster images with exceptional
image quality. It gives 100 frames/s, 15 mm axial resolution
and 10mmscan diameter.14e16 FDOCT systems do not require
proximal occlusion. The coronary vessel is transiently
rendered free of blood by a bolus injection of saline, contrast,
or other solution, injected at rates of 2e4 ml/s.14e16 C7XR FD
OCT system comeswith a Dragonfly Catheter. It has fast flush,
spiral pullback acquisition. The imaging catheter is a Rapid
exchange (Rx) imaging catheter. An automated 20 mm/spullback within the monorail rapid exchange catheter allows
imaging of a 6cm long coronary segment during a 3-s
injection.14e16 The acquired images are stored in the OCT
console. The stored images were analyzed subsequently.
Fibrous plaque produces homogenous high-intensity signal,
lipid laden plaque produces low-intensity, irregular signal
with indistinct and irregular borders. Calcified plaque pro-
duces low-intensity, sharp bordered, “textured” appearances
(Fig. 1aec). A thin cap fibroatheroma (TCFA) was defined as a
homogenous area in the arterial wall with a low refractive
index, separated from the vessel lumen by a capsule having a
Fig. 3 e Edge dissection.
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Cross-sectional OCT images were analyzed at 1 mm interval.
Quantitative analysis was performed to determine degree
of stenosis. The presence of dissections at the stent edges,
tissue prolapse through stent struts and zones of incomplete
stent apposition were evaluated. A dissection flap is a linear
rim of tissue with a clear separation from the vessel wall,
plaque, or the stent struts (Fig 3).14,15 Tissue prolapse was
defined as protrusion of tissue through an imaginary arc
connecting two adjacent struts without apparent surface
disruption. It is defined as occurring if depth of protrusion is
>50 mm (Fig 4).17
Incomplete stent apposition was defined as a measured
distance greater than the strut thickness for bare metal stents
or greater than the sum of the thickness of the strut plus
polymer for drug eluting stents (Fig 5). OCT was also done in
patients after implantation of bioabsorbable scaffold (Fig. 6a
and b).3. Results
OCT was done in a total of forty-five patients who underwent
successful PCI. Twenty-eight patients were male, mean age
was 54 years, 24 patients were hypertensive, 27 patients were
diabetics, and 13were smokers (Table 1). PCIwas performed to
treat acute STEMI in 10 patients; whereas NSTEMI/UA was
present in 27 patients. LAD lesion was imaged in 28 patients,
LCX lesion was imaged in 9 patients, and RCA lesion was
imaged in 8 patients. Baseline angiographic and procedural
characteristic is given in Table 2. Stent malapposition was
detected in 24% (11 patients) of intervention requiring further
balloon dilatation. Thin cap fibroatheromas (TCFA) with a
fibrous caps measuring between 0.02 and 0.06 mm, were
detected in 3 patients (in the region of the stenosis in the 2
patients), although it was not considered as an indication of
PCI. Some amount of tissue prolapse through the stent struts
was observed in almost all the patients. In incomplete stent
apposition, the maximum separation between the stent and
the arterial wall ranged between 0.04 and 0.5 mm and it
involved up to 180 of the vessel circumference. TheFig. 2 e Thin cap fibrous atheroma.anticoagulation used was same as that for PCI (70e100 IU of
unfractionated heparin per kilogram body weight). In two
patients IV Bivalirudin was used. No patient had thrombus
formation around the OCT catheter. None of the patients
developed angina, electrocardiographic changes, or compli-
cations during the procedure and during hospital stay. The
OCT study prolonged the duration of the procedure in each
patient by about 10e20 min (average of 15 min). In total, OCT
was used for 70 times along with PCI. Our strategy or decision
for reintervention was changed on 46 occasions out of 70
timeswhen OCTwas used (65%) (Table 3). In absolute number,
strategy was changed in 28 (62%) out of 45 patients after OCT.
Alteration of stent length was done in 14 patients (56% cases
when evaluated pre PCI). Alteration of stent diameter was
done in 9 patients (36% cases when evaluated pre PCI).
Treatment of malapposition was done in 11 patients (24.4% of
total cases). Further, balloon dilatation for vessel expansion inFig. 4 e Tissue prolapse through stent strut.
Fig. 5 e Stent malapposition.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 3 1e3 734calcified lesion was done in 7 patients (15.5% of total cases).
Edge dissection requiring further balloon dilatation or stent-
ing was seen in 4 patients (8.8% of total cases).
One case of left main stenting was done after detecting
proximal edge dissection on OCT. Small amount of tissue
protrusion was not taken as criteria for reintervention.Fig. 6 e (a) OCT picture of well apposed bioabsorbable stent.
(b) Overlapping bioabsorbable stent.4. Discussion
In this study we evaluated how OCT changes our strategy
during stent implantation in the Indian milieu. This report
shows that OCT can provide clinically useful and more
importantly, clinically actionable information about sub
optimal stent deployment despite satisfactory angiographic
images after PCI. We found that OCT showed important re-
sidual pathology post PCI and such findings changed stent
management strategies in a significant number of patients
(62% of the 45 cases coming to PCI in our study). The main
changes suggested after OCT were alteration of stent length
(56%), stent diameter (36%) and treatment of stent malap-
position (24%). OCT thus may have a useful role in PCI even in
the Indian context. It should, however, be remembered that
OCT use is still is in its infancy; while OCT with its superior
resolution will show more abnormalities than other currently
available imaging modalities, it is not certain at this time that
fixing all these “OCT visualized” abnormalitieswill necessarily
improve patient outcomes. Experience with IVUS and other
imaging modalities show that the correlation between some
abnormal findings seen on IVUS post PCI and subsequent
clinical outcome is highly variable. While some studies have
reported similar rates of adverse events in patients with and
without acute incomplete stent apposition or plaque prolapse
as assessed by IVUS,18e21 others have demonstrated a high
prevalence of abnormal findings in the IVUS study followingstent implantation in patients who develop acute stent
thrombosis.22e25 OCT has distinct advantages in some areas.
Given its high resolution, OCT is considered to be superior to
IVUS for the assessment of the dissection, zones of incomplete
stent apposition, tissue prolapse following PCI.11 Thrombus is
poorly seen on IVUS,26 whereas it is well visualized by OCT.
OCT is very helpful in assessing stent apposition with over-
lapping stents.27 OCT was extensively used in ABSORB trial to
assess acute results of PCI aswell as to determine the degree of
absorption of bioabsorbable stent during follow up.28 Lesion
characteristics such as lipid and calcium content can be
defined prior to the intervention and these findings can be
predictive of post-procedure myocardial infarction.29 OCT
studies have shown the morphologic features of plaques that
are potential predictors of subsequent progression and acute
coronary syndromes (ACS).6,30 ThoughOCT is potentiallymore
accurate than IVUS at determining lesion severity, it still re-
mains an anatomical imaging technique and as yet is unlikely
to replace a physiological technique like FFR.31
Table 1 e Baseline clinical characteristics.
Characteristics Pre PCI and PCI OCT Post PCI OCT
No. of patients 25 20
Age (years) 54  9 56  10
Men 16 (64%) 12 (60%)
Hypertension 13 (52%) 11 (55%)
DM 15 (61%) 12 (60%)
Dyslipidemia 8 (32%) 6 (30%)
Current smokers 7 (28%) 6 (30%)
Clinical Presentation
Stable angina 14 (56%) 5 (25%)
UA/NSTEMI 7 (28%) 4 (20%)
STEMI 4 (16%) 11 (55%)
Table 3 e Changes in management strategy after OCT.
Over all management changes No. of patients
Treatment of malapposition 11 (24.4% of total cases)
Further balloon dilatation for vessel
expansion in calcified lesion
7 (15.5% of total cases)
Further balloon dilatation/stenting
for edge dissection
4 (8.8% of total cases)
Alteration of stent length 14 (56% cases when
evaluated pre PCI)
Alteration of stent diameter 9 (36% cases when
evaluated pre PCI)
One case of left main stenting after detecting proximal edge
dissection
Total no of times OCT performed ¼ 70 (pre & post PCI in 25pt, pre
PCI only in 20pt)
Total no of occasions decision was changed post OCT ¼ 46 (65.5%)
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 3 1e3 7 35Unlike with IVUS, there have been few prospective studies
of clinical outcomes in patients undergoing OCT. In the
absence of such data, there are currently no definite proven
indications for the use of OCT in the clinical setting.14,15 The
potential clinical indications for OCT are similar to IVUS
which include angiographically uncertain lesions, evaluation
for allograft vasculopathy, lesion assessment pre PCI, and
evaluation of stent deployment post PCI, evaluation of
mechanism of in-stent restenosis and stent thrombosis. The
results of CLI-OPCI study, which included 335 in the OCT
group and 335 in the angiography group suggest that the use of
OCT can improve clinical outcomes of patients undergoing
PCI.32 Developed in the 1980s, intravascular ultrasound (IVUS)
is currently the most commonly utilized methods for endo-
vascular imaging. The clinical role for IVUS was established
via both prospective and retrospective studies with specific
guidelines for its use.33,34 Advantages of IVUS is its penetra-
tion of 4e8 mm inside the vessel wall, unlike OCT which can
only penetrate about 2e3 mm, better imaging of aorto-ostial
lesions and no need of contrast. A study comparing IVUS
and OCT found that, OCT guidance for stent implantation was
associated with smaller stent expansion as compared to
IVUS.35 On the other hand another study comparing IVUS and
OCT suggests that FD OCT generates similar reference lumen
dimensions, as well as better detection of malapposition, tis-
sue prolapse and disease severity compared with IVUS.36 Ul-
timately, clinical outcome data will determine whether OCT
will super-seed IVUS or just plain angiography and this isTable 2 e Baseline angiographic & procedural
characteristics.
Characteristics Pre PCI and post
PCI e OCT (n ¼ 25)
Post PCI
OCT (n ¼ 20)
Lesion length (mm) 23.8  6.3 22.1  6.7
Stent diameter (mm) 2.86  0.28 2.90  0.24
Stent length (mm) 25.9  5.9 24.8  6.7
RVD (mm) 2.68  0.34 2.71  0.33
MLD (mm)
Pre-procedure 0.81  0.48 0.70  0.53
Post-procedure 2.73  0.39 2.60  0.46
Mean lumen CSA
(mm 2)
6.0  1.5 6.3  1.6
Mean stent CSA
(mm 2)
7.4  1.8 6.8  1.5
Presence of thrombi 18 (24%) 8 (22%)currently an open unresolved question. Novel hybrid IVUS
and OCT imaging catheters are in the making and have syn-
ergistic advantages; preliminary ex vivo images using a hybrid
IVUS-OCT catheter have demonstrated feasibility.375. Limitations
This study should be considered in the light of several limi-
tations. It was a single center, case series kind of descriptive
study with a limited number of patients. The study end points
were subjective interpretations and given that OCT resolution
is far superior to those of current methods, naturally there
was no independent method to verify these findings. As there
are no specific guidelines on indications of OCT, the use of
OCT was left at operator’s discretion and it might have been
used in more challenging cases e this will limit its applica-
bility in the more general population coming to PCI. Costs
were not analyzed and it is not known if the use of OCT was
cost effective. Long term follow up is lacking and it is not
known if using OCTmade a difference in long term outcomes.
Large randomized controlled studies using OCTwill be needed
to prove its clinical efficacy.6. Conclusion
OCT is changing the way we see coronary lesion pathophysi-
ology. Our data, one of the first experiences in India, confirm
that OCT allows for better visualization of lumen, plaque,
thrombus, as well as stent apposition, & dissection post PCI.
Presently we are at the beginning stage to establish how this
imaging informationmight be best used to guidemanagement
and optimize the angiographic results. More extensive, long
term studies will be needed to assess the clinical outcome of
these interventions.Conflicts of interest
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